These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7463335)

  • 1. Impurities in drugs V: Meprobamate.
    Lawrence RC; Lovering EG; Poirier MA; Watson JR
    J Pharm Sci; 1980 Dec; 69(12):1444-5. PubMed ID: 7463335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impurities in drugs III: Trihexyphenidyl.
    Poirier MA; Curran NM; McErlane KM; Lovering EG
    J Pharm Sci; 1979 Sep; 68(9):1124-7. PubMed ID: 501534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impurities in drugs IV: Indomethacin.
    Curran NM; Lovering EG; McErlane KM; Watson JR
    J Pharm Sci; 1980 Feb; 69(2):187-9. PubMed ID: 7359321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impurities in drugs I: Imipramine, desipramine, and their formulations.
    McErlane KM; Curran NM; Lovering EG
    J Pharm Sci; 1977 Jul; 66(7):1015-8. PubMed ID: 886436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impurities in drugs II: meperidine and its formulations.
    McErlane KM; Wood RJ; Matsui F; Lovering EG
    J Pharm Sci; 1978 Jul; 67(7):958-61. PubMed ID: 660515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance.
    Karthikeyan K; Arularasu GT; Murali V; Pillai KC
    J Pharm Biomed Anal; 2011 Jan; 54(1):208-12. PubMed ID: 20727702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on psychotropic drugs. Determination of meprobamate by means of TLC-FID analyser (author's transl)].
    Ono M; Shimamine M; Takahashi K
    Eisei Shikenjo Hokoku; 1978; (96):67-70. PubMed ID: 750046
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative determination of carisoprodol, phenacetin, and caffeine in tablets by near-IR spectrometry and their identification by TLC.
    Allen L
    J Pharm Sci; 1974 Jun; 63(6):912-6. PubMed ID: 4853991
    [No Abstract]   [Full Text] [Related]  

  • 9. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability-indicating HPLC method for the determination of impurities in meprobamate with refractive index detection.
    Karthikeyan K; Balaji TS; Shanmugasundaram P; Chandrasekara Pillai K
    J Chromatogr Sci; 2010 Mar; 48(3):212-8. PubMed ID: 20223088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of potential impurities of rabeprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Sudhakar P; Babu JM; Vyas K; Reddy PR; Mukkanti K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1262-9. PubMed ID: 17134865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural identification and characterization of potential impurities of pantoprazole sodium.
    Reddy GM; Bhaskar BV; Reddy PP; Ashok S; Sudhakar P; Babu JM; Vyas K; Mukkanti K
    J Pharm Biomed Anal; 2007 Oct; 45(2):201-10. PubMed ID: 17629653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of impurities in sulfasalazine.
    Zalipsky JJ; Patel DM; Reavey-Cantwell NH
    J Pharm Sci; 1978 Mar; 67(3):387-91. PubMed ID: 25326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An automated colorimetric method for the determination of meprobamate and other N-unsubstituted carbamates in pharmaceutical products.
    Cullen LF; Heckman LJ; Papariello GJ
    J Pharm Sci; 1969 Dec; 58(12):1537-9. PubMed ID: 5353277
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis and evaluation of the impurity of felodipine and its tablets].
    Zhang N; Yu LJ; Li J; Tong JW; Meng J; Zhang QM; Shi YQ
    Yao Xue Xue Bao; 2012 Feb; 47(2):223-8. PubMed ID: 22512035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of impurities in commercial lots of sodium saccharin produced by the Sherwin-Williams process. I. Chemistry.
    Riggin RM; Kinzer GW
    Food Chem Toxicol; 1983 Feb; 21(1):1-10. PubMed ID: 6681789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thin-layer chromatography of hypnotics, narcotics, meprobamate and Bemegride as pure substances].
    Riechert M
    Med Lab (Stuttg); 1969 May; 22(5):110-7. PubMed ID: 5802983
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification, isolation and characterization of process related impurities in ezetimibe.
    Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
    J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin--a national survey V: Determination of aspirin and impurities in enteric coated tablets and suppository formulations and in vitro dissolution of enteric coated tablets.
    Kirchhoefer RD; Jefferson E; Flinn PE
    J Pharm Sci; 1982 Sep; 71(9):1049-52. PubMed ID: 7131273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.